ITOC

Healthcare Medical Devices

iTonic Holdings Ltd.

$0.25

-0.03 -11.17% today

Price History

Not enough data

Key Stats

Market Cap

29.15M

Avg Volume

790,465

EPS

-$0.26

52W High

$1.15

52W Low

$0.22

Div. Yield

0.0%

Valuation

P/B Ratio

1.24

P/S Ratio

52.38

EV/EBITDA

-3.52

EV/Revenue

50.78

Margins

Gross Margin 60.9%

Operating Margin (5036.1%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

49.5%

Return on Equity

(67.0%)

Return on Assets

(32.3%)

Liquidity & Leverage

Current Ratio

17.39

Quick Ratio

1.96

Debt / Equity

0.01

Total Cash

2.22M

Total Debt

244,457

About

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.